The Genetics of Peak Bone Mass

Osteoporosis in Men: The Effects of Gender on Skeletal Health

Volumn , Issue , 2009, Pages 149-163

  Gennari, Luigi ^a   Klein, Robert ^b   Ferrari, Serge ^c  

^a UNIVERSITY OF SIENA   (Italy)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84890060941     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-374602-3.00012-2     Document Type: Chapter

References (92)

1. Ralston S.H. Genetic determinants of bone mass and osteoporotic fracture. Principles of Bone Biology 2008, 1611-1634. Elsevier, San Diego. third ed. J.P. Bilezikian, L.G. Riggs, T.J. Martin (Eds.).
2. Albagha O.M.E., Ralston S.H. Genetics and osteoporosis. Rheum. Dis. Clin. N. Am. 2006, 32:659-680.
3. Seeman E., Tsalamandris C., Formica C., Hopper J.L., McKay J. Reduced femoral neck bone density in the daughters of women with hip fractures: the role of low peak bone density in the pathogenesis of osteoporosis. J. Bone Miner. Res. 1994, 9:739-743.
4. Cohen-Solal M.E., Baudoin C., Omouri M., Kuntz D., De Vernejoul M.C. Bone mass in middle-aged osteoporotic men and their relatives: familial effect. J. Bone Miner. Res. 1998, 13:1909-1914.
5. Van Pottelbergh I., Goemaere S., Zmierczak H., De Bacquer D., Kaufman J.M. Deficient acquisition of bone during maturation underlies idiopathic osteoporosis in men: evidence from a three-generation family study. J. Bone Miner. Res. 2003, 18:303-311.
6. Smith D.M., Nance W.E., Kang K.W., Christian J.C., Johnston C.C. Genetic factors in determining bone mass. J. Clin. Invest. 1973, 52:2800-2808.
7. Ferrari S., Rizzoli R., Slosman D., Bonjour J.P. Familial resemblance for bone mineral mass is expressed before puberty. J. Clin. Endocrinol. Metab. 1998, 83:358-361.
8. Jones G., Nguyen T.V. Association between maternal peak bone mass and bone mass in prepubertal male and female children. J. Bone Miner. Res. 2000, 15:1998-2004.
9. Seeman E. Pathogenesis of bone fragility in women and men. Lancet 2002, 359:1841-1850.
10. Karasik D., Ferrari S.L. Contribution of gender-specific genetic factors to osteoporosis risk. Ann. Hum. Genet. 2008, 72:696-714.
11. Naganathan V., Macgregor A., Snieder H., Nguyen T., Spector T., Sambrook P. Gender differences in the genetic factors responsible for variation in bone density and ultrasound. J. Bone Miner. Res. 2002, 17:725-733.
12. Deng H.W., Livshits G., Yakovenko K., et al. Evidence for a major gene for bone mineral density/content in human pedigrees identified via probands with extreme bone mineral density. Ann. Hum. Genet. 2002, 66:61-74.
13. Pelat C., Van Pottelbergh I., Cohen-Solal M., et al. Complex segregation analysis accounting for GxE of bone mineral density in European pedigrees selected through a male proband with low BMD. Ann. Hum. Genet. 2007, 71:29-42.
14. Huang Q.Y., Recker R.R., Deng H.W. Searching for osteoporosis genes in the post-genome era: progress and challenges. Osteoporos. Int. 2003, 14:701-715.
15. Byers P.H., Wallis G.A., Willing M.C. Osteogenesis imperfecta: translation of mutation to phenotype. Med. Genet 1991, 28:433-442.
16. Smith E.P., Boyd J., Frank G.R., et al. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N. Engl. J. Med. 1994, 331:1056-1061.
17. Gennari L., Bilezikian J., Khosla S. Estrogen effects on bone in the male skeleton. Principles of Bone Biology 2008, 1819-1837. Elsevier, San Diego. third ed. J.P. Bilezikian, L.G. Riggs, T.J. Martin (Eds.).
18. Gong Y., Slee R.B., Fukai N., et al. LDL Receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 2001, 107:513-523.
19. Hartikka H., Makitie O., Mannikko M., et al. Heterozygous mutations in the LDL receptor-related protein 5 (LRP5) gene are associated with primary osteoporosis in children. J. Bone Miner. Res. 2005, 20:783-789.
20. Crabbe P., Balemans W., Willaert A., et al. Missense mutations in LRP5 are not a common cause of idiopathic osteoporosis in adult men. J. Bone Miner. Res. 2005, 20:1951-1959.
21. Mani A., Radhakrishnan J., Wang H., et al. LRP6 mutation in a family with early coronary disease and metabolic risk factors. Science 2007, 315:1278-1282.
22. Boyden L.M., Mao J., Belsky J., et al. High bone density due to a mutation in LDL-receptor-related protein 5. N. Engl. J. Med. 2002, 346:1513-1521.
23. Van Wesenbeeck L., Cleiren E., Gram J., et al. Six novel missense mutations in the LDL receptor-related protein 5 (LRP5) gene in different conditions with an increased bone density. Am. J. Hum. Genet. 2003, 72:763-771.
24. Balemans W., Ebeling M., Patel N., et al. Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST). Hum. Mol. Genet. 2001, 10:537-543.
25. Balemans W., Patel N., Ebeling M., et al. Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease. J. Med. Genet 2002, 39:91-97.
26. Gardner J.C., van Bezooijen R.L., Mervis B., et al. Bone mineral density in sclerosteosis: affected individuals and gene carriers. J. Clin. Endocrinol. Metab. 2005, 90:6392-6395.
27. Ioannidis J.P., Ng M.Y., Sham P.C., et al. Meta-analysis of genome-wide scans provides evidence for sex- and site-specific regulation of bone mass. J. Bone Miner. Res. 2007, 22:173-183.
28. Karasik D., Cupples L.A., Hannan M.T., Kiel D.P. Age, gender, and body mass effects on quantitative trait loci for bone mineral density: the Framingham study. Bone 2003, 33:308-316.
29. Ralston S.H., Galwey N., Mackay I., et al. Loci for regulation of bone mineral density in men and women identified by genome wide linkage scan: the FAMOS study. Hum. Mol. Genet 2005, 14:943-951.
30. Kaufman J.M., Ostertag A., Saint-Pierre A., et al. Genome-wide linkage screen of bone mineral density (BMD) in European pedigrees ascertained through a male relative with low BMD values: evidence for quantitative trait loci on 17q21-23, 11q12-13, 13q12-14 and 22q11. J. Clin. Endocrinol. Metab. 2008, 93:3755-3762.
31. Zhang F., Xiao P., Yang F., et al. A whole genome linkage scan for QTLs underlying peak bone mineral density. Osteoporos. Int. 2008, 19:303-310.
32. Streeten E.A., McBride D.J., Pollin T.I., et al. Quantitative trait loci for BMD identified by autosome-wide linkage scan to chromosomes 7q and 21q in men from the Amish Family Osteoporosis Study. J. Bone Miner. Res. 2006, 21:1433-1442.
33. Styrkarsdottir U., Cazier J.B., Kong A., et al. Linkage of osteoporosis to chromosome 20p12 and association to BMP2. PLoS. Biol. 2003, 1(3):E69.
34. Richards J.B., Rivadeneira F., Inouye M., et al. Bone mineral density, osteoporosis, and osteoporotic fractures: a genome-wide association study. Lancet 2008, 371:1505-1512.
35. Styrkarsdottir U., Halldorsson B.V., Gretarsdottir S., et al. Multiple genetic loci for mineral density and fracture. N. Engl. J. Med. 2008, 358:2355-2365.
36. Braidman I., Baris C., Wood L., et al. Preliminary evidence for impaired estrogen receptor - a protein expression in osteoblasts and osteocytes from men with idiopathic osteo-porosis. Bone 2006, 26:423-427.
37. Gennari L., Merlotti D., De Paola V., et al. Estrogen receptor gene polymorphisms and the genetics of osteoporosis: a huge review. Am. J. Epidemiol. 2005, 161:307-320.
38. Ioannidis J.P., Stavrou I., Trikalinos T.A., et al. ER-alpha genetics meta-analysis. Association of polymorphisms of the estrogen receptor alpha gene with bone mineral density and fracture risk in women: a meta-analysis. J. Bone Miner. Res. 2002, 17:2048-2060.
39. Ioannidis J.P., Ralston S.H., Bennett S.T., et al. Differential genetic effects of ESR1 gene polymorphisms on osteoporosis outcomes. J. Am. Med. Assoc. 2004, 292(2):105-114.
40. Lorentzon M., Lorentzon R., Backstrom T., Nordstrom P. Estrogen receptor gene polymorphism, but not estradiol levels, is related to bone density in healthy adolescent boys: a cross-sectional and longitudinal study. J. Clin. Endocrinol. Metab. 1999, 84:4597-4601.
41. Boot A.M., van der Sluis I.M., de Muinck Keizer-Schrama S.M., et al. Estrogen receptor alpha gene polymorphisms and bone mineral density in healthy children and young adults. Calcif. Tissue Int. 2004, 74:495-500.
42. Pennisi P., Chevalley T., Manen D., et al. Genetic variation in estrogen receptor alpha and interleukin-6 is associated with bone mass acquisition in prepubertal girls and boys: interaction with calcium supplements. J. Bone Min. Res. 2005, 20(Suppl. 1):S343.
43. Willing M.C., Torner J.C., Burns T.L., et al. Gene polymorphisms, bone mineral density and bone mineral content in young children: the Iowa Bone Development Study. Osteoporos. Int. 2003, 14:650-658.
44. Khosla S., Riggs B.L., Atkinson E.J., et al. Relationship of estrogen receptor genotypes to bone mineral density and to rates of bone loss in men. J. Clin. Endocrinol. Metab. 2004, 89:1808-1816.
45. Shearman A.M., Karasik D., Gruenthal K.M., et al. Estrogen receptor beta polymorphisms are associated with bone mass in women and men: the Framingham study. J. Bone Miner. Res. 2004, 19:773-781.
46. Gennari L., Nuti R., Bilezikian J.P. Aromatase activity and bone homeostasis in men. J. Clin. Endocrinol. Metab. 2004, 89:5898-5907.
47. Remes T., Vaisanen S.B., Mahonen A., et al. Aerobic exercise and bone mineral density in middle-aged Finnish men: a controlled randomized trial with reference to androgen receptor, aromatase, and estrogen receptor α gene polymorphisms. Bone 2003, 32:412-420.
48. Lorentzon M., Swanson C., Eriksson A.L., Mellström D., Ohlsson C. Polymorphisms in the aromatase gene predict areal BMD as a result of affected cortical bone size: the GOOD study. J. Bone Miner. Res. 2006, 21:332-339.
49. Gennari L., Brandi M.L. Genetics of male osteoporosis. Calcif. Tissue Int. 2001, 69:200-204.
50. Gennari L., Merlotti D., De Paola V., Martini G., Nuti R. Update on the pharmacogenetics of the vitamin D receptor and osteoporosis. Pharmacogenomics 2009, 10:417-433.
51. Ferrari S., Rizzoli R., Chevallery T., Slosman D., Eisman J.A., Bonjour J.P. Vitamin D receptor gene polymorphisms and change in lumbar spine bone mineral density. Lancet 1995, 345:423-424.
52. Ferrari S., Manen D., Bonjour J.P., Slosman D., Rizzoli R. Bone mineral mass and calcium and phosphate metabolism in young men: relationship with vitamin D receptor allelic polymorphisms. J. Bone Miner. Res. 1999, 84:2043-2048.
53. Grundberg E., Lau E.M., Pastinen T., et al. Vitamin D receptor 3' haplotypes are unequally expressed in primary human bone cells and associated with increased fracture risk: the MrOS Study in Sweden and Hong Kong. J. Bone Miner. Res. 2007, 22:832-840.
54. Vilariño-Güell C., Miles L.J., Duncan E.L., et al. PTHR1 polymorphisms influence BMD variation through effects on the growing skeleton. Calcif. Tissue Int. 2007, 81:270-278.
55. Ferrari S.L., Deutsch S., Baudoin C., et al. LRP5 gene polymorphisms and idiopathic osteoporosis in men. Bone 2005, 37:770-775.
56. Ferrari S.L., Deutsch S., Choudhury U., et al. Polymorphisms in the low-density lipoprotein receptor-related protein 5 (LRP5) gene are associated with variation in vertebral bone mass, vertebral bone size, and stature in whites. Am. J. Hum. Genet 2004, 74:866-875.
57. Van Meurs J.B., Schuit S.C., Weel A.E., et al. Association of 5' estrogen receptor alpha gene polymorphisms with bone mineral density, vertebral bone area and fracture risk. Hum. Mol. Genet 2003, 12:1745-1754.
58. Kiel D.P., Ferrari S.L., Cupples L.A., et al. Genetic variation at the low-density lipoprotein receptor-related protein 5 (LRP5) locus modulates Wnt signaling and the relationship of physical activity with bone mineral density in men. Bone 2007, 40:587-596.
59. Brixen K., Beckers S., Peeters A., et al. Polymorphisms in the low-density lipoprotein receptor-related protein 5 (LRP5) gene are associated with peak bone mass in non-sedentary men: results from the Odense Androgen Study. Calcif. Tissue Int. 2007, 81:421-429.
60. Saarinen A., Välimäki V.V., Välimäki M.J., et al. The A1330V polymorphism of the low-density lipoprotein receptor-related protein 5 gene (LRP5) associates with low peak bone mass in young healthy men. Bone 2007, 40:1006-1012.
61. van Meurs J.B., Trikalinos T.A., Ralston S.H., et al. Large-scale analysis of association between LRP5 and LRP6 variants and osteoporosis. J. Am. Med. Assoc. 2008, 299:1277-1290.
62. Sims A.M., Shephard N., Carter K., et al. Genetic analyses in a sample of individuals with high or low BMD shows association with multiple Wnt pathway genes. J. Bone Miner. Res. 2008, 23:499-506.
63. Uitterlinden A.G., Arp P., Paeper B., et al. Polymorphisms in the sclerosteosis/van Buchem disease gene (SOST) region are associated with bone-mineral density in elderly whites. Am. J. Hum. Genet 2004, 75:1032-1045.
64. McGuigan F.E., Murray L., Gallagher A., et al. Genetic and environmental determinants of peak bone mass in young men and women. J. Bone Miner. Res. 2002, 17:1273-1279.
65. Rosen C.J., Kurland E.S., Vereault D., et al. Association between serum insulin growth factor-I (IGF-I) and a simple sequence repeat in IGF-I gene: implications for genetic studies of bone mineral density. J. Clin. Endocrinol. Metab. 1998, 83:2286-2290.
66. Takacs I., Koller D.L., Peacock M., et al. Sibiling pair linkage and association studies between bone mineral density and the insulin-like growth factor I gene locus. J. Clin. Endocrinol. Metab. 1999, 84:4467-4471.
67. Abrahamsen B., Jørgensen H.L., Nielsen T.L., et al. MTHFR c.677C > T polymorphism as an independent predictor of peak bone mass in Danish men - results from the Odense Androgen Study. Bone 2006, 38:215-219.
68. Lorentzon M., Eriksson A.L., Mellström D., Ohlsson C. The COMT val158met polymorphism is associated with peak BMD in men. J. Bone Miner. Res. 2004, 19:2005-2011.
69. Lorentzon M., Lorentzon R., Nordström P. Interleukin-6 gene polymorphism is related to bone mineral density during and after puberty in healthy white males: a cross-sectional and longitudinal study. J. Bone Miner. Res. 2000, 15:1944-1949.
70. Ichikawa S., Koller D.L., Johnson M.L., et al. Human ALOX12, but not ALOX15, is associated with BMD in white men and women. J. Bone Miner. Res. 2006, 21:556-564.
71. Hsu Y.H., Niu T., Terwedow H.A., et al. Variation in genes involved in the RANKL/RANK/OPG bone remodeling pathway are associated with bone mineral density at different skeletal sites in men. Hum. Genet 2006, 118:568-577.
72. Deng H.W., Xu F.H., Huang Q.Y., et al. A whole-genome linkage scan suggests several genomic regions potentially containing quantitative trait loci for osteoporosis. J. Clin. Endocrinol. Metab. 2002, 87:5151-5159.
73. Devoto M., Shimoya K., Caminis J., et al. First-stage autosomal genome screen in extended pedigrees suggests genes predisposing to low bone mineral density on chromosomes 1p, 2p and 4q. Eur. J. Hum. Genet 1998, 6:151-157.
74. Klein R.F., Allard J., Avnur Z., et al. Regulation of bone mass in mice by the lipoxygenase gene Alox15. Science 2004, 303:229-232.
75. Hirschhorn J.N., Gennari L. Bona fide genetic associations with bone mineral density. N. Engl. J. Med. 2008, 358:2403-2405.
76. Ackert-Bicknell C.L., Demissie S., Marín de Evsikova C., et al. PPARG by dietary fat interaction influences bone mass in mice and humans. J. Bone Miner. Res. 2008, 23:1398-1408.
77. Allayee H., Andalibi A., Mehrabian M. Using inbred mouse strains to identify genes for complex diseases. Front. Biosci. 2006, 11:1216-1226.
78. Shmookler Reis R.J., Ebert R.H. Animal models for discovery and assessment of genetic determinants of osteoporosis. Osteoporos. Int. 2003, 14(Suppl. 5):S100-S106.
79. Malakoff D. The rise of the mouse, biomedicine's model mammal. Science 2000, 288:248-253.
80. Flaherty L., Herron B., Symula D. Genomics of the future: identification of quantitative trait loci in the mouse. Genome. Res. 2005, 15:1741-1745.
81. Benes H., Weinstein R.S., Zheng W., et al. Chromosomal mapping of osteopenia-associated quantitative trait loci using closely related mouse strains. J. Bone Miner. Res. 2000, 15:626-633.
82. Klein R.F., Carlos A.S., Vartanian K.A., et al. Confirmation and fine mapping of chromosomal regions influencing peak bone mass in mice. J. Bone Miner. Res. 2001, 16:1953-1961.
83. Glatt V., Canalis E., Stadmeyer L., Bouxsein M.L. Age-related changes in trabecular architecture differ in female and male C57BL/6J mice. J. Bone Miner. Res. 2007, 22:1197-1207.
84. Mödder U.I., Sanyal A., Xu J., O'Malley B.W., Spelsberg T.C., Khosla S. The skeletal response to estrogen is impaired in female but not in male steroid receptor coactivator (SRC)-1 knock out mice. Bone 2008, 42:414-421.
85. DeMambro V.E., Clemmons D.R., Horton L.G., et al. Gender-specific changes in bone turnover and skeletal architecture in igfbp-2-null mice. Endocrinology 2008, 149:2051-2061.
86. Dubrow S.A., Hruby P.M., Akhter M.P. Gender specific LRP5 influences on trabecular bone structure and strength. J. Musculoskelet. Neuron. Interact. 2007, 7:166-173.
87. Orwoll E.S., Belknap J.K., Klein R.F. Gender specificity in the genetic determinants of peak bone mass. J. Bone Miner. Res. 2001, 16:1962-1971.
88. Klein R.F., Mitchell S.R., Phillips T.J., Belknap J.K., Orwoll E.S. Quantitative trait loci affecting peak bone mineral density in mice. J. Bone Miner. Res. 1998, 13:1648-1656.
89. Klein R.F., Turner R.J., Skinner L.D., et al. Mapping quantitative trait loci that influence femoral cross-sectional area in mice. J. Bone Miner. Res. 2002, 17:1752-1760.
90. Turner C.H., Sun Q., Schriefer J., et al. Congenic mice reveal sex-specific genetic regulation of femoral structure and strength. Calcif. Tissue Int. 2003, 73:297-303.
91. Robling A.G., Warden S.J., Shultz K.L., Beamer W.G., Turner C.H. Genetic effects on bone mechanotransduction in congenic mice harboring bone size and strength quantitative trait loci. J. Bone Miner. Res. 2007, 22:984-991.
92. Edderkaoui B., Baylink D.J., Beamer W.G., Shultz K.L., Wergedal J.E., Mohan S. Genetic regulation of femoral bone mineral density: complexity of sex effect in chromosome 1 revealed by congenic sublines of mice. Bone 2007, 41:340-445.